Finance

Lists
C26:FRA
CellaVision AB
€15,04
-1,83%
(-0,28) 1D
1 Okt., 08:02:44 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for C26...
Open
€15,04
High
€15,04
Low
€15,04
Mkt. cap
4,20 mjd
Avg. vol.
65,00
Volume
0,00
52-wk high
€17,06
52-wk low
€10,64
No. of employees
251
Open
€15,04
High
€15,04
Low
€15,04
Mkt. cap
4,20 mjd
Avg. vol.
65,00
Volume
0,00
52-wk high
€17,06
52-wk low
€10,64
No. of employees
251
News stories
From web sources and news partners
About CellaVision AB
CEOSimon Østergaard
Employees251
Founded1994
Headquarters-
SectorMedical device
Websitecellavision.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
175,63 m
197,20 m
166,43 m
199,89 m
Cost of goods sold
54,33 m
65,41 m
52,43 m
59,11 m
Cost of revenue
54,33 m
65,41 m
52,43 m
59,11 m
Research and development expenses
28,68 m
21,95 m
29,68 m
29,77 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
53,07 m
54,75 m
55,82 m
69,81 m
Operating expense
81,76 m
76,69 m
85,49 m
99,58 m
Total operating expenses
136,09 m
142,10 m
137,93 m
158,69 m
Operating income
39,54 m
55,10 m
28,50 m
41,19 m
Other non operating income
-
-
-
-
EBT including unusual items
39,23 m
54,54 m
28,49 m
41,08 m
EBT excluding unusual items
39,23 m
54,54 m
28,49 m
41,08 m
Income tax expense
7,89 m
11,93 m
5,98 m
8,45 m
Effective tax rate
20,11%
21,87%
21,00%
20,56%
Other operating expenses
-
-
-
-
Net income
31,34 m
42,61 m
22,50 m
32,63 m
Net profit margin
17,84%
21,61%
13,52%
16,33%
Earnings per share
1,31
1,79
0,94
1,37
Interest and investment income
78,00 k
8,88 m
446,00 k
480,00 k
Interest expense
-395,00 k
-1,44 m
-459,00 k
-596,00 k
Net interest expenses
-317,00 k
7,43 m
-13,00 k
-116,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
47,82 m
65,46 m
36,92 m
49,57 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme